中国同辐股份有限公司2025年度营收约人民币69.79亿元至72.06亿元,净利润约人民币3.02亿元至3.22亿元

公告速递
Feb 12

本季度信息

根据公告,中国同辐股份有限公司预计,截至2025年12月31日止年度,营收约人民币69.79亿元至人民币72.06亿元,同比减少约5%至8%;净利润约人民币3.02亿元至人民币3.22亿元,同比减少约20%至25%。

公司表示,目前经营运作正常。营业收入下滑主要来自核医疗装备业务板块的收益下降;净利润减少则受到旗下深圳市中核海得威生物科技有限公司补缴税费及滞纳金的影响。

业务分项

公告显示,核医疗装备分部营收出现下滑,进一步拖累了整体营收表现。该分部业绩下降与市场环境及补缴税费事项共同影响了公司整体利润水平。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10